Literature DB >> 23861090

The glial scar in spinal cord injury and repair.

Yi-Min Yuan1, Cheng He.   

Abstract

Glial scarring following severe tissue damage and inflammation after spinal cord injury (SCI) is due to an extreme, uncontrolled form of reactive astrogliosis that typically occurs around the injury site. The scarring process includes the misalignment of activated astrocytes and the deposition of inhibitory chondroitin sulfate proteoglycans. Here, we first discuss recent developments in the molecular and cellular features of glial scar formation, with special focus on the potential cellular origin of scar-forming cells and the molecular mechanisms underlying glial scar formation after SCI. Second, we discuss the role of glial scar formation in the regulation of axonal regeneration and the cascades of neuro-inflammation. Last, we summarize the physical and pharmacological approaches targeting the modulation of glial scarring to better understand the role of glial scar formation in the repair of SCI.

Entities:  

Mesh:

Year:  2013        PMID: 23861090      PMCID: PMC5561940          DOI: 10.1007/s12264-013-1358-3

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  137 in total

1.  Ethyl pyruvate promotes spinal cord repair by ameliorating the glial microenvironment.

Authors:  Yimin Yuan; Zhida Su; Yingyan Pu; Xiujie Liu; Jingjing Chen; Feng Zhu; Yanling Zhu; Han Zhang; Cheng He
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Protective effects of oral creatine supplementation on spinal cord injury in rats.

Authors:  O N Hausmann; K Fouad; T Wallimann; M E Schwab
Journal:  Spinal Cord       Date:  2002-09       Impact factor: 2.772

3.  Origin of new glial cells in intact and injured adult spinal cord.

Authors:  Fanie Barnabé-Heider; Christian Göritz; Hanna Sabelström; Hirohide Takebayashi; Frank W Pfrieger; Konstantinos Meletis; Jonas Frisén
Journal:  Cell Stem Cell       Date:  2010-10-08       Impact factor: 24.633

Review 4.  Proteoglycans and injury of the central nervous system.

Authors:  Fumiko Matsui; Atsuhiko Oohira
Journal:  Congenit Anom (Kyoto)       Date:  2004-12       Impact factor: 1.409

5.  Macroglial plasticity and the origins of reactive astroglia in experimental autoimmune encephalomyelitis.

Authors:  Fuzheng Guo; Yoshiko Maeda; Joyce Ma; Monica Delgado; Jiho Sohn; Laird Miers; Emily Mills Ko; Peter Bannerman; Jie Xu; Yazhou Wang; Chengji Zhou; Hirohide Takebayashi; David Pleasure
Journal:  J Neurosci       Date:  2011-08-17       Impact factor: 6.167

6.  Leukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitors.

Authors:  Daniel Fisher; Bin Xing; John Dill; Hui Li; Hai Hiep Hoang; Zhenze Zhao; Xiao-Li Yang; Robert Bachoo; Stephen Cannon; Frank M Longo; Morgan Sheng; Jerry Silver; Shuxin Li
Journal:  J Neurosci       Date:  2011-10-05       Impact factor: 6.167

7.  PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration.

Authors:  Yingjie Shen; Alan P Tenney; Sarah A Busch; Kevin P Horn; Fernando X Cuascut; Kai Liu; Zhigang He; Jerry Silver; John G Flanagan
Journal:  Science       Date:  2009-10-15       Impact factor: 47.728

8.  Origin and progeny of reactive gliosis: A source of multipotent cells in the injured brain.

Authors:  Annalisa Buffo; Inmaculada Rite; Pratibha Tripathi; Alexandra Lepier; Dilek Colak; Ana-Paula Horn; Tetsuji Mori; Magdalena Götz
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-25       Impact factor: 11.205

9.  Transcriptional regulation of scar gene expression in primary astrocytes.

Authors:  Paul Gris; Allyson Tighe; David Levin; Rahul Sharma; Arthur Brown
Journal:  Glia       Date:  2007-08-15       Impact factor: 7.452

Review 10.  Scar-mediated inhibition and CSPG receptors in the CNS.

Authors:  Kartavya Sharma; Michael E Selzer; Shuxin Li
Journal:  Exp Neurol       Date:  2012-07-24       Impact factor: 5.330

View more
  60 in total

Review 1.  Glial Contributions to Neural Function and Disease.

Authors:  Matthew N Rasband
Journal:  Mol Cell Proteomics       Date:  2015-09-04       Impact factor: 5.911

2.  An update on spinal cord injury research.

Authors:  Yimin Zou
Journal:  Neurosci Bull       Date:  2013-08       Impact factor: 5.203

3.  Anti-inflammatory effects of Metformin improve the neuropathic pain and locomotor activity in spinal cord injured rats: introduction of an alternative therapy.

Authors:  Khashayar Afshari; Amir Dehdashtian; Nazgol-Sadat Haddadi; Arvin Haj-Mirzaian; Arad Iranmehr; Mohammad Ali Ebrahimi; Seyed Mohammad Tavangar; Hedyeh Faghir-Ghanesefat; Fatemeh Mohammadi; Nastaran Rahimi; Abbas Norouzi Javidan; Ahmad Reza Dehpour
Journal:  Spinal Cord       Date:  2018-06-29       Impact factor: 2.772

Review 4.  Scar-modulating treatments for central nervous system injury.

Authors:  Dingding Shen; Xiaodong Wang; Xiaosong Gu
Journal:  Neurosci Bull       Date:  2014-06-24       Impact factor: 5.203

Review 5.  Current status of cell-mediated regenerative therapies for human spinal cord injury.

Authors:  Tongming Zhu; Qisheng Tang; Huasong Gao; Yiwen Shen; Luping Chen; Jianhong Zhu
Journal:  Neurosci Bull       Date:  2014-05-10       Impact factor: 5.203

6.  Chronic Spinal Cord Injury Reduces Gastrin-Releasing Peptide in the Spinal Ejaculation Generator in Male Rats.

Authors:  J Walker Wiggins; Natalie Kozyrev; Jonathan E Sledd; George G Wilson; Lique M Coolen
Journal:  J Neurotrauma       Date:  2019-07-10       Impact factor: 5.269

7.  Purmorphamine as a Shh Signaling Activator Small Molecule Promotes Motor Neuron Differentiation of Mesenchymal Stem Cells Cultured on Nanofibrous PCL Scaffold.

Authors:  Naghmeh Bahrami; Mohammad Bayat; Abdolreza Mohamadnia; Mehrdad Khakbiz; Meysam Yazdankhah; Jafar Ai; Somayeh Ebrahimi-Barough
Journal:  Mol Neurobiol       Date:  2016-09-14       Impact factor: 5.590

8.  Glial restricted precursors maintain their permissive properties after long-term expansion but not following exposure to pro-inflammatory factors.

Authors:  Kazuo Hayakawa; Christopher Haas; Ying Jin; Julien Bouyer; Takanobu Otsuka; Itzhak Fischer
Journal:  Brain Res       Date:  2015-10-21       Impact factor: 3.252

9.  Safety and Efficacy of Rose Bengal Derivatives for Glial Scar Ablation in Chronic Spinal Cord Injury.

Authors:  Nandadevi Patil; Vincent Truong; Mackenzie H Holmberg; Nicolas S Lavoie; Mark R McCoy; James R Dutton; Eric G Holmberg; Ann M Parr
Journal:  J Neurotrauma       Date:  2018-04-19       Impact factor: 5.269

Review 10.  Concise Review: Bridging the Gap: Novel Neuroregenerative and Neuroprotective Strategies in Spinal Cord Injury.

Authors:  Christopher S Ahuja; Michael Fehlings
Journal:  Stem Cells Transl Med       Date:  2016-04-29       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.